Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI

Area of Science:

• Cardiology
• Interventional Cardiology
• Mechanical Circulatory Support

Background:

• Complex high-risk indicated percutaneous coronary intervention (CHIP) requires mechanical circulatory support (MCS) to prevent hemodynamic instability.
• Limited comparative data exist for different MCS devices in CHIP patients declined for surgery.

Purpose of the Study:

• To compare the efficacy and safety of Impella CP versus veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in CHIP patients.
• To evaluate major adverse cardiac events (MACE) and mortality rates between the two MCS devices.

Main Methods:

• Retrospective analysis of a multicenter observational study.
• Inclusion of CHIP patients supported by Impella CP or VA-ECMO who were declined surgery.
• Evaluation of periprocedural hemodynamic instability, MACE, and mortality (in-hospital and 30-day).

Main Results:

• No significant difference in periprocedural hemodynamic instability between Impella CP (3.7%) and VA-ECMO (14.3%).
• Similar rates of Major Adverse Cardiac Events (MACE) for Impella CP (30.7%) and VA-ECMO (21.4%).
• No significant differences in in-hospital or 30-day mortality between the two support systems.

Conclusions:

• Both Impella CP and VA-ECMO provide comparable hemodynamic support in CHIP patients.
• The choice between Impella CP and VA-ECMO does not significantly impact MACE or mortality outcomes in this patient cohort.
• Further research may explore specific patient subgroups that could benefit more from one device over the other.